Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Living Cell Technologies ( (AU:1AI) ) has shared an announcement.
Algorae Pharmaceuticals Limited has notified the market of the issue of 199,013,513 unquoted options, each expiring on 1 December 2029, under the ASX code 1AIAT. The options, which are not intended to be quoted on the ASX, were issued as part of previously announced transactions, signalling a significant expansion of the company’s unquoted equity base and potentially affecting capital structure and future shareholder dilution dynamics.
More about Living Cell Technologies
Algorae Pharmaceuticals Limited is an Australia-listed biotechnology and pharmaceuticals company focused on developing pharmaceutical products, with its securities traded on the ASX under the issuer code 1AI.
YTD Price Performance: 50.0%
Average Trading Volume: 3,168,696
Technical Sentiment Signal: Buy
Current Market Cap: A$25.33M
See more insights into 1AI stock on TipRanks’ Stock Analysis page.